Overview

Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS

Status:
Not yet recruiting
Trial end date:
2030-08-23
Target enrollment:
Participant gender:
Summary
This is a multicenter, single arm, open-label, extension study to evaluate the long-term safety, tolerability, and efficacy of iptacopan in participants with aHUS.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals